Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

vTv Therapeutics Inc. Director's Dealing 2016

May 16, 2016

34596_dirs_2016-05-16_e76bf1d3-eba6-4d59-95c1-29a9202d987e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: vTv Therapeutics Inc. (VTVT)
CIK: 0001641489
Period of Report: 2016-05-12

Reporting Person: Parker Craig C (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-12 Director stock option (right to buy) $5.35 A 15000.00 Acquired 2026-05-12 Class A common stock (15000.00) Direct

Footnotes

F1: The option vests in monthly equal installments over the three year period beginning on May 12, 2016